An investigation for investors in NASDAQ:UTHR shares was announced over potential breaches of fiduciary duties by certain United Therapeutics directors.
Investors who purchased shares of United Therapeutics Corporation (NASDAQ:UTHR) and currently hold any of those NASDAQ:UTHR shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain United Therapeutics directors breached their fiduciary duties.
Silver Spring, MD based United Therapeutics Corporation reported that its annual Total Revenue rose from over $1.28 billion in 2014 to over $1.46 billion in 2015 and that its Net Income increased from $340.07 million in 2014 to $651.64 million in 2015. Shares of United Therapeutics Corporation (NASDAQ:UTHR) declined from as high as $188.15 per share in June 2015 to as low as $98.33 per share in June 27, 2016.
On November 18, 2016, NASDAQ:UTHR shares closed at $130.94 per share.
Those who purchased NASDAQ:UTHR shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com